Effects of atorvastatin therapy on hypercholesterolernic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine

被引:53
作者
Bolayirli, Ibrahim Murat
Aslan, Mahmure
Balci, Huriye
Altug, Tuncay
Hacibekiroglu, Munire
Seven, Arzu
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Fikret Biyal Cent Res Lab, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Dept Biochem & Clin Biochem, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Med Fac, Expt Anim Res & Breeding Lab, Istanbul, Turkey
关键词
oxidative stress; hypercholesterolemia; PON1; ADMA; homocysteine;
D O I
10.1016/j.lfs.2007.04.027
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypercholesterolemia is characterized with changes in lipid profile, nitric oxide pathway and oxidative stress markers. This study is designed to evaluate the effects of hypercholesterolemic diet and atorvastatin therapy on oxidative stress, lipid peroxide and thiobarbituric acid reactive substances (TBARS), NO pathway markers, nitric oxide(NO) and asymmetric dimethylarginine (ADMA), homocysteine, and paraoxonase activity (PON1) in rabbits. Twenty rabbits fed with high-cholesterol diet for 8 weeks were randomly divided into 2 groups on the fourth week of the hypercholesterolemic diet. First group was fed with high-cholesterol diet alone, whereas the second group with the same cholesterol diet plus atorvastatin (0.3 mg/kg/day) for 4 weeks. High-cholesterol diet increased total cholesterol, low density lipoprotein (LDL-C), high density lipoprotein (HDL-C), ADMA, TBARS and lipid peroxide levels and reduced PON1 activity and NO levels in rabbits. Four weeks of atorvastatin therapy significantly increased HDL-C, PON1 activity and reduced LDL-C, TBARS and lipid peroxide concentrations. Atorvastatin therapy is beneficial in decreasing oxidative stress related with hypercholesterolemia, mainly affecting lipid profile and PON1 activity. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 50 条
[1]   Efficacy of simvastatin and pumpkin-seed oil in the management of dietary-induced hypercholesterolemia [J].
AlZuhair, H ;
AbdElFattah, AA ;
AbdElLatif, HA .
PHARMACOLOGICAL RESEARCH, 1997, 35 (05) :403-408
[2]  
Amerongen GPV, 2000, CIRCULATION, V102, P2803
[3]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[4]   Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits [J].
BodeBoger, SM ;
Boger, RH ;
Kienke, S ;
Junker, W ;
Frolich, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :598-603
[5]   Association of asymmetric dimethylarginine and endothelial dysfunction [J].
Böger, RH .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (11) :1467-1472
[6]   Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits - Comparison with lovastatin [J].
Boger, RH ;
BodeBoger, SM ;
Brandes, RP ;
Phivthongngam, L ;
Bohme, M ;
Nafe, R ;
Mugge, A ;
Frolich, JC .
CIRCULATION, 1997, 96 (04) :1282-1290
[7]  
Böger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173
[8]   The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor [J].
Böger, RH .
CARDIOVASCULAR RESEARCH, 2003, 59 (04) :824-833
[9]  
BOGER RH, 2004, NUTRITION, V134, P2842
[10]  
Buege J A, 1978, Methods Enzymol, V52, P302